Medicare Enrolled

Dr. Lalitha Ravichandran, M.D.

Nephrology · Pomona, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1 MEDICAL PARK DR, Pomona, NY 10970
8453625600
In practice since 2006 (20 years)
NPI: 1346214186 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ravichandran from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ravichandran? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ravichandran

Dr. Lalitha Ravichandran is a nephrology specialist in Pomona, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ravichandran performed 1,632 Medicare services across 659 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ravichandran received a total of $7,172 from 39 pharmaceutical and/or device companies across 286 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nephrology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ravichandran is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 27% volume in NY $7,172 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,632
Medicare services
Top 27% in NY for nephrology
659
Unique beneficiaries
$145
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~82 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
423 $108 $240
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
417 $109 $225
Dialysis services for patients 20 or older
Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month.
191 $319 $700
Hemodialysis, single evaluation
A dialysis procedure to filter waste from the blood, performed with a physician's evaluation.
157 $64 $150
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
157 $197 $576
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
99 $75 $150
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
88 $158 $420
Dialysis services for adults, 2-3 visits per month
This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month.
66 $266 $700
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
22 $148 $320
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
12 $127 $129
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,172
Total received (2018-2024)
Avg $1,025/year across 7 years
Top 14% in NY for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
286
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,742 (94.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$430 (6.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,230
2023
$1,619
2022
$1,714
2021
$472
2020
$153
2019
$1,454
2018
$530

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Fresenius USA Marketing, Inc.
$305
Amgen Inc.
$153
Novartis Pharmaceuticals Corporation
$113
Travere Therapeutics, Inc.
$83
Otsuka America Pharmaceutical, Inc.
$68
Vifor Pharma, Inc.
$62
Boehringer Ingelheim Pharmaceuticals, Inc.
$59
Alnylam Pharmaceuticals Inc.
$59
AstraZeneca Pharmaceuticals LP
$56
Lilly USA, LLC
$43
Ardelyx, Inc.
$37
Aurinia Pharma U.S., Inc.
$34
Ultragenyx Pharmaceutical Inc.
$32
Kyowa Kirin, Inc.
$28
PFIZER INC.
$26
Mallinckrodt Hospital Products Inc.
$23
OPKO Pharmaceuticals, LLC
$18
ANI Pharmaceuticals, Inc.
$17
CALLIDITAS THERAPEUTICS US INC.
$15
Top 3 companies account for 46.3% of 2024 payments
All-time payments by company (2018-2024) ›
Fresenius USA Marketing, Inc.
$1,026
AstraZeneca Pharmaceuticals LP
$863
OPKO Pharmaceuticals, LLC
$548
Amgen Inc.
$455
Horizon Therapeutics plc
$401
Bayer HealthCare Pharmaceuticals Inc.
$315
Vifor Pharma, Inc.
$283
GlaxoSmithKline, LLC.
$243
Relypsa, Inc.
$219
Otsuka America Pharmaceutical, Inc.
$210
Travere Therapeutics, Inc.
$176
Amarin Pharma Inc.
$165
Mallinckrodt Enterprises LLC
$159
Mallinckrodt Hospital Products Inc.
$158
W. L. Gore & Associates, Inc.
$140
Novartis Pharmaceuticals Corporation
$137
Bayer Healthcare Pharmaceuticals Inc.
$133
Aurinia Pharma U.S., Inc.
$128
Novo Nordisk Inc
$125
Boehringer Ingelheim Pharmaceuticals, Inc.
$116
BOSTON SCIENTIFIC CORPORATION
$113
Ultragenyx Pharmaceutical Inc.
$109
ANI Pharmaceuticals, Inc.
$107
Alexion Pharmaceuticals, Inc.
$107
Calliditas Therapeutics US Inc.
$87
Alnylam Pharmaceuticals Inc.
$87
Exeltis, USA Inc.
$86
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$78
CALLIDITAS THERAPEUTICS US INC.
$77
AKEBIA THERAPEUTICS INC
$49
PFIZER INC.
$44
Lilly USA, LLC
$43
Ardelyx, Inc.
$37
Mallinckrodt LLC
$28
Kyowa Kirin, Inc.
$28
Strongbridge US INC.
$28
Retrophin, Inc.
$24
Exact Sciences Corporation
$23
GENZYME CORPORATION
$18
Top 3 companies account for 34.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AURYXIA · Aranesp · Auryxia · BENLYSTA · Cologuard Collection Kit · Crysvita · FABRY-DISEASE · FARXIGA · Fabhalta · GIVLAARI · GORE VIABAHN Endoprosthesis · IBSRELA · JARDIANCE · JYNARQUE · KEVEYIS · KRYSTEXXA · Kerendia · LOKELMA · LUPKYNIS · Ozempic · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Parsabiv · RAYALDEE · Rayaldee · Rayaldee (old) · SOLIRIS · TARPEYO · TAVNEOS · TEZSPIRE · Tavneos · ULTOMIRIS · Ultomiris · Vascepa · Velphoro · Veltassa · WATCHMAN · XIFAXAN
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a nephrology specialist in Pomona?
Compare nephrologists in the Pomona area by procedure volume, costs, and industry payment transparency.
Browse nephrologists nearby

Geographic Context

Nephrologists within 10 mi
201
Per 100K population
59.3
County median income
$110,631
Nearest hospital
GOOD SAMARITAN HOSPITAL OF SUFFERN
4.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Ravichandran is a clinical cardiology specialist, with above-average Medicare volume (top 27% in NY), with low-engagement industry engagement in the top 14% of NY peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Ravichandran experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Ravichandran performed 423 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ravichandran receive payments from pharmaceutical companies?
Yes. Dr. Ravichandran received a total of $7,172 from 39 companies across 286 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ravichandran's costs compare to other nephrologists in Pomona?
Dr. Ravichandran's average Medicare payment per service is $145. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ravichandran) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →